High-dose oral baclofen: experience in patients with multiple sclerosis
- PMID: 1944915
- DOI: 10.1212/wnl.41.11.1829
High-dose oral baclofen: experience in patients with multiple sclerosis
Abstract
We reviewed a 10% random sample of charts from an outpatient clinic for multiple sclerosis to determine the frequency with which baclofen was prescribed for spasticity in high doses (greater than 80 mg/d). About 20% of patients had taken high-dose baclofen, and 15% were still receiving a high dose. Taking a high dose was not associated with discontinuing treatment.
Comment in
-
Baclofen for spasticity.Neurology. 1992 Oct;42(10):2056. doi: 10.1212/wnl.42.10.2056-a. Neurology. 1992. PMID: 1407599 No abstract available.
Similar articles
-
The use of baclofen in treatment of spasticity in multiple sclerosis.Can J Neurol Sci. 1979 Aug;6(3):351-4. doi: 10.1017/s0317167100023994. Can J Neurol Sci. 1979. PMID: 385132 Clinical Trial.
-
Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study.NeuroRehabilitation. 2010;27(2):117-20. doi: 10.3233/NRE-2010-0587. NeuroRehabilitation. 2010. PMID: 20871140 No abstract available.
-
[Treatment of spasticity by intrathecal baclofen treatment].Duodecim. 1993;109(14):1251-5. Duodecim. 1993. PMID: 8062701 Review. Finnish. No abstract available.
-
Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.J Rehabil Med. 2011 May;43(6):511-4. doi: 10.2340/16501977-0811. J Rehabil Med. 2011. PMID: 21533331
-
Intrathecal baclofen in multiple sclerosis.Eur Neurol. 2014;72 Suppl 1:32-4. doi: 10.1159/000367623. Epub 2014 Sep 26. Eur Neurol. 2014. PMID: 25278123 Review. No abstract available.
Cited by
-
Phosphinic acid derivatives as baclofen agonists and antagonists in the mammalian spinal cord: an in vivo study.Exp Brain Res. 1994;101(1):59-72. doi: 10.1007/BF00243217. Exp Brain Res. 1994. PMID: 7843303
-
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury.Neurotherapeutics. 2019 Jul;16(3):858-867. doi: 10.1007/s13311-019-00713-8. Neurotherapeutics. 2019. PMID: 30725362 Free PMC article.
-
Baclofen in the treatment of alcohol use disorder: tailored doses matter.Alcohol Alcohol. 2024 Jan 17;59(2):agad090. doi: 10.1093/alcalc/agad090. Alcohol Alcohol. 2024. PMID: 38266071 Free PMC article. Review.
-
Drugs used to treat spasticity.Drugs. 2000 Mar;59(3):487-95. doi: 10.2165/00003495-200059030-00006. Drugs. 2000. PMID: 10776831 Review.
-
A benefit-risk assessment of baclofen in severe spinal spasticity.Drug Saf. 2004;27(11):799-818. doi: 10.2165/00002018-200427110-00004. Drug Saf. 2004. PMID: 15350152 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical